Cidara Therapeutics Inc. (NASDAQ: CDTX)
$23.5900
+0.3700 ( +3.01% ) 26.4K
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
Market Data
Open
$23.5900
Previous close
$23.2200
Volume
26.4K
Market cap
$245.58M
Day range
$22.0490 - $23.5690
52 week range
$10.0040 - $24.9900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jul 19, 2024 |
8-k | 8K-related | 15 | Jul 18, 2024 |
4 | Insider transactions | 1 | Jun 11, 2024 |
ars | Annual reports | 1 | Jun 03, 2024 |
def | Proxies and info statements | 8 | Jun 03, 2024 |
pre | Proxies and info statements | 4 | May 23, 2024 |
8-k | 8K-related | 13 | May 20, 2024 |
8-k | 8K-related | 15 | May 15, 2024 |
10-q | Quarterly Reports | 74 | May 15, 2024 |
8-k | 8K-related | 77 | May 03, 2024 |